AURX 1.50 Nuo Therapeutics, Inc.
| Range: | 0.252-0.98 | Vol Avg: | 11236 | Last Div: | 0 | Changes: | 0.07 |
| Beta: | -773.47 | Cap: | 0.03B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Oct 24 2017 | Empoloyees: | 9 | ||
| CUSIP: | 67059V209 | CIK: | 0001091596 | ISIN: | US67059V2097 | Country: | US |
| CEO: | Mr. David E. Jorden CPA | Website: | https://www.nuot.com | ||||
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow